REG - CVS Group plc - Transaction in Own Shares
Yesterday 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251231:nRSe2058Na&default-theme=true
RNS Number : 2058N CVS Group plc 31 December 2025
31 December 2025
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 30 December 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 30/12/2025
Aggregate number of Ordinary Shares purchased: 7,816
Lowest price paid per share (GBp): 1,266.00
Highest price paid per share (GBp): 1,284.00
Volume weighted average price paid per share (GBp): 1,278.10
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,711,273 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 70,711,273 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 1,029,510 Ordinary Shares in aggregate at a weighted average price
of 1,221.04 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
305 1274 30/12/2025 08:09:00 1361359287617626 XLON
107 1272 30/12/2025 08:21:40 1361359287618151 XLON
68 1268 30/12/2025 09:05:23 1361359287620071 XLON
80 1268 30/12/2025 09:18:28 1361359287620422 XLON
197 1266 30/12/2025 11:03:19 1361359287624152 XLON
8 1268 30/12/2025 11:29:41 1361359287625079 XLON
16 1268 30/12/2025 11:29:41 1361359287625080 XLON
56 1268 30/12/2025 11:29:41 1361359287625081 XLON
6 1268 30/12/2025 11:29:41 1361359287625082 XLON
110 1272 30/12/2025 11:43:36 1361359287625435 XLON
6 1272 30/12/2025 11:43:36 1361359287625436 XLON
320 1272 30/12/2025 11:43:36 1361359287625434 XLON
146 1272 30/12/2025 11:43:36 1361359287625437 XLON
36 1272 30/12/2025 11:43:36 1361359287625438 XLON
12 1272 30/12/2025 11:43:36 1361359287625439 XLON
16 1272 30/12/2025 11:43:36 1361359287625440 XLON
4 1272 30/12/2025 11:43:36 1361359287625441 XLON
1 1272 30/12/2025 11:43:36 1361359287625442 XLON
2 1272 30/12/2025 11:43:36 1361359287625443 XLON
1 1272 30/12/2025 11:43:36 1361359287625444 XLON
4 1272 30/12/2025 11:43:36 1361359287625445 XLON
1 1272 30/12/2025 11:43:36 1361359287625446 XLON
3 1272 30/12/2025 11:43:36 1361359287625447 XLON
2 1272 30/12/2025 11:43:36 1361359287625448 XLON
1 1272 30/12/2025 11:43:36 1361359287625449 XLON
146 1272 30/12/2025 11:43:36 1361359287625450 XLON
36 1272 30/12/2025 11:43:45 1361359287625465 XLON
125 1272 30/12/2025 11:43:51 1361359287625484 XLON
2 1272 30/12/2025 11:57:01 1361359287625951 XLON
68 1274 30/12/2025 12:02:03 1361359287626110 XLON
6 1274 30/12/2025 12:08:15 1361359287626304 XLON
6 1274 30/12/2025 12:08:15 1361359287626305 XLON
62 1276 30/12/2025 12:57:19 1361359287627763 XLON
68 1278 30/12/2025 12:59:07 1361359287627832 XLON
70 1276 30/12/2025 13:05:01 1361359287628057 XLON
217 1276 30/12/2025 13:05:01 1361359287628058 XLON
189 1276 30/12/2025 13:05:03 1361359287628066 XLON
374 1278 30/12/2025 13:38:31 1361359287629420 XLON
160 1278 30/12/2025 13:38:31 1361359287629421 XLON
15 1276 30/12/2025 13:40:00 1361359287629515 XLON
108 1276 30/12/2025 13:43:35 1361359287629635 XLON
200 1280 30/12/2025 13:46:03 1361359287629770 XLON
68 1280 30/12/2025 14:00:44 1361359287630123 XLON
68 1284 30/12/2025 14:30:08 1361359287631556 XLON
155 1284 30/12/2025 14:31:00 1361359287631729 XLON
371 1284 30/12/2025 14:31:00 1361359287631730 XLON
61 1282 30/12/2025 14:35:12 1361359287632600 XLON
62 1282 30/12/2025 14:35:12 1361359287632601 XLON
123 1282 30/12/2025 14:35:12 1361359287632602 XLON
55 1282 30/12/2025 14:35:12 1361359287632603 XLON
225 1282 30/12/2025 14:35:12 1361359287632604 XLON
115 1280 30/12/2025 14:51:28 1361359287634654 XLON
92 1280 30/12/2025 14:51:29 1361359287634655 XLON
230 1284 30/12/2025 14:59:35 1361359287635272 XLON
294 1284 30/12/2025 14:59:35 1361359287635273 XLON
329 1280 30/12/2025 15:06:01 1361359287635916 XLON
195 1280 30/12/2025 15:06:01 1361359287635917 XLON
11 1280 30/12/2025 15:34:56 1361359287638557 XLON
35 1280 30/12/2025 15:34:56 1361359287638558 XLON
1 1280 30/12/2025 15:34:56 1361359287638559 XLON
3 1280 30/12/2025 15:34:56 1361359287638560 XLON
12 1280 30/12/2025 15:34:56 1361359287638561 XLON
5 1280 30/12/2025 15:34:56 1361359287638562 XLON
1 1280 30/12/2025 15:34:56 1361359287638563 XLON
79 1280 30/12/2025 15:34:56 1361359287638564 XLON
17 1280 30/12/2025 15:34:56 1361359287638565 XLON
6 1280 30/12/2025 15:34:56 1361359287638566 XLON
30 1280 30/12/2025 15:34:56 1361359287638567 XLON
96 1280 30/12/2025 15:43:42 1361359287639483 XLON
35 1280 30/12/2025 15:43:42 1361359287639484 XLON
32 1280 30/12/2025 15:43:42 1361359287639485 XLON
70 1280 30/12/2025 15:43:42 1361359287639486 XLON
291 1280 30/12/2025 15:43:43 1361359287639487 XLON
59 1280 30/12/2025 15:45:03 1361359287639688 XLON
95 1280 30/12/2025 15:45:03 1361359287639689 XLON
75 1280 30/12/2025 15:45:03 1361359287639690 XLON
218 1280 30/12/2025 15:45:04 1361359287639691 XLON
197 1280 30/12/2025 16:09:15 1361359287642278 XLON
111 1280 30/12/2025 16:09:15 1361359287642279 XLON
5 1280 30/12/2025 16:26:34 1361359287644298 XLON
149 1280 30/12/2025 16:26:34 1361359287644299 XLON
67 1280 30/12/2025 16:26:34 1361359287644300 XLON
95 1280 30/12/2025 16:26:34 1361359287644302 XLON
96 1280 30/12/2025 16:28:22 1361359287644546 XLON
16 1280 30/12/2025 16:28:22 1361359287644547 XLON
106 1280 30/12/2025 16:28:24 1361359287644548 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint Broker)
+44 (0)20 3207
7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSWPGRAPUPAPGU
Copyright 2019 Regulatory News Service, all rights reservedRecent news on CVS
See all newsREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Total Voting Rights
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
Announcement